Similar articles

• Monoclonal Antibodies against Zika Virus: Therapeutics and Their Implications for Vaccine Design.

  Wang Q, Yan J, Gao GF. Wang Q, et al. J Virol. 2017 Sep 27;91(20):e01049-17. doi: 10.1128/JVI.01049-17. Print 2017 Oct 15. J Virol. 2017. PMID: 28768876 Free PMC article. Review.
• Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development.

  Roth C, Delgado FG, Simon-Lorière E, Sakuntabhai A. Roth C, et al. Int J Environ Res Public Health. 2018 Feb 23;15(2):385. doi: 10.3390/ijerph15020385. Int J Environ Res Public Health. 2018. PMID: 29473899 Free PMC article. Review.
• [Zoonotic infection with simian foamy viruses: potent neutralizing antibodies].

  Buseyne F. Buseyne F. Virologie (Montrouge). 2019 Feb 1;23(1):35-39. doi: 10.1684/vir.2019.0758. Virologie (Montrouge). 2019. PMID: 31131828 French. No abstract available.
• Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.

  Swanstrom JA, Plante JA, Plante KS, Young EF, McGowan E, Gallichotte EN, Widman DG, Heise MT, de Silva AM, Baric RS. Swanstrom JA, et al. mBio. 2016 Jul 19;7(4):e01123-16. doi: 10.1128/mBio.01123-16. mBio. 2016. PMID: 27435464 Free PMC article.
• Monoclonal Antibodies Show Promise as the Key to Zika Virus Diagnostics.

  Tran A. Tran A. Clin Chem. 2017 Mar;63(3):790-791. doi: 10.1373/clinchem.2016.267971. Clin Chem. 2017. PMID: 28242837 No abstract available.